Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
MEDIVATION Add to My Watchlist (NSDQ: MDVN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Medivation 36.77 +0.30 (+0.82%) 6,403
201 Spear Street
3rd floor
San Francisco, CA 94105 US
(415) 543-3470
(415) 543-3113 fax
www.medivation.net
CEO Dr. David T. Hung, M.D.
Auditor PricewaterhouseCoopers LLP
Exchange Traded NQ
ISIN Number US58501N1019
CIK Number 1011835
NAICS Code 325414
Business Summary
A biopharmaceutical company focused on the development of novel small molecule drugs to treat serious diseases for which there are limited treatment options.
Number of Employees 59
Share Fundamentals
Market Cap 1.23B
Shares Outstanding 33.51M
Float 31.27M
Short Interest 5.46M
Financial Strength
Revenue (TTM) $61,599,000
Earnings (TTM) -$36,436,000
Quick Ratio 2.6:1
Current Ratio 2.7:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin -54.3%
Profit Margin -51.8%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs